Claudin expression in Barrett's esophagus and adenocarcinoma

被引:54
作者
Gyorffy, H
Holczbauer, A
Nagy, P
Szabó, Z
Kupcsulik, P
Páska, C
Papp, J
Schaff, Z
Kiss, A
机构
[1] Semmelweis Univ, Dept Pathol 2, H-1091 Budapest, Hungary
[2] Natl Med Ctr, Dept Pathol, H-1135 Budapest, Hungary
[3] Municipal St Laszlo Hosp, H-1097 Budapest, Hungary
[4] Semmelweis Univ, Dept Surg 1, H-1082 Budapest, Hungary
[5] Semmelweis Univ, Dept Internal Med 1, H-1083 Budapest, Hungary
关键词
Barrett's esophagus; adenocarcinoma; claudin; tight junction; immunohistochemistry;
D O I
10.1007/s00428-005-0045-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Claudins (CLDNs) are key molecules in cell adhesion, polarity, and control of paracellular solute transport. Several studies suggested that changes in claudin pattern have a role in cancer development. This study aimed to detect alterations in CLDN 1, 2, 3, 4, and 7 expression patterns in Barrett's esophagus (BE) and adenocarcinoma (ACC) compared with that in foveolar epithelium (FOV), normal squamous epithelium (SQ), and squamous cell carcinoma (SQCC). One hundred twenty five surgically or endoscopically removed, paraffin-embedded cases were studied by immunohistochemistry and analyzed statistically. BE, ACC, and FOV were dissected from 30 paraffin-embedded samples for further mRNA expression analysis. CLDN 7 was the dominating type in all epithelia and carcinomas, but its expression did not differ in normal and altered tissues. CLDN 1 expression was significantly increased in SQCC compared with that in SQ. CLDNs 3 and 4 were significantly elevated both in BE and ACC compared with that in FOV. CLDN 2 expression increased significantly in ACCs compared with that in BE. This is the first report proving similarities and differences regarding claudin expression pattern in BE and ACC compared with that in FOV and SQ. Our data prove a close link in CLDN pattern between BE and ACC, adding further evidence that BE is an alteration preceding esophageal ACC.
引用
收藏
页码:961 / 968
页数:8
相关论文
共 43 条
[31]   Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut [J].
Rahner, C ;
Mitic, LL ;
Anderson, JM .
GASTROENTEROLOGY, 2001, 120 (02) :411-422
[32]   Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study [J].
Resnick, MB ;
Konkin, T ;
Routhier, J ;
Sabo, E ;
Pricolo, VE .
MODERN PATHOLOGY, 2005, 18 (04) :511-518
[33]   Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: The role of histology and immunohistochemistry [J].
Sarbia, M ;
Donner, A ;
Franke, C ;
Gabbert, HE .
HUMAN PATHOLOGY, 2004, 35 (03) :371-376
[34]   Tight junctions and human diseases [J].
Norimasa Sawada ;
Masaki Murata ;
Keisuke Kikuchi ;
Makoto Osanai ;
Hirotoshi Tobioka ;
Takashi Kojima ;
Hideki Chiba .
Medical Electron Microscopy, 2003, 36 (3) :147-156
[35]   Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells [J].
Singh, AB ;
Harris, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (05) :3543-3552
[36]   Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma [J].
Sobel, G ;
Páska, C ;
Szabó, I ;
Kiss, A ;
Kádár, A ;
Schaff, Z .
HUMAN PATHOLOGY, 2005, 36 (02) :162-169
[37]  
SWAMI S, 1995, AM J GASTROENTEROL, V90, P1808
[38]  
Tanaka Y, 2000, INT J ONCOL, V16, P725
[39]   Claudin-1,-3 and-4 proteins and mRNA expression in benign and malignant breast lesions:: a research study [J].
Tokés, AM ;
Kulka, J ;
Paku, S ;
Szik, A ;
Páska, C ;
Novák, PK ;
Szilák, L ;
Kiss, A ;
Bögi, K ;
Schaff, Z .
BREAST CANCER RESEARCH, 2005, 7 (02) :R296-R305
[40]  
van Dekken H, 1999, CANCER RES, V59, P748